Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It focuses on schizophrenia.
Multiple locations, including AnaheimThis study is completed in the United States and in Ukraine. It is testing Long-term Safety, Tolerability, and Efficacy of KarXT for schizophrenia.
Multiple locations, including Bentonville
This study has public registry information. It focuses on ADHD and currently lists study information in the United States.
In New YorkThis study is completed. It focuses on bipolarity and currently lists study information in the United States.
In Boston
This study is completed. It focuses on PTSD and currently lists study information in the United States.
Multiple locations, including InglewoodThis study is active but not recruiting. It focuses on depression and currently lists study information in the United States.
In New YorkThis study is completed. It focuses on PTSD and currently lists study information in the United States.
In Las VegasThis study is completed. It focuses on anxiety and currently lists study information in the United States.
Multiple locations, including OrangeThis study is completed. It focuses on PTSD and currently lists study information in the United States.
In Los AngelesThis study is enrolling by invitation. It focuses on PTSD and currently lists participation information in the United States.
In College StationThis study is completed. It focuses on PTSD and currently lists study information in Sweden.
In StockholmThis study is completed. It focuses on ADHD and currently lists study information in Norway.
In BergenHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.